Review
Open Access
Pre-exposure prophylaxis for HIV: effective and underused
Amanda Hempel, Mia J. Biondi, Jean-Guy Baril and Darrell H.S. Tan
CMAJ September 06, 2022 194 (34) E1164-E1170; DOI: https://doi.org/10.1503/cmaj.220645
Amanda Hempel
Department of Medicine (Hempel, Tan), University of Toronto; Toronto Centre for Liver Disease (Biondi), University Health Network; School of Nursing (Biondi), York University; Division of Infectious Disease (Tan), St. Michael’s Hospital, Toronto, Ont.; Department of Family Medicine (Baril), Centre Hospitalier de l’Université de Montréal; Clinique de médecine urbaine du Quartier Latin (Baril), Montréal, Que.
MDMia J. Biondi
Department of Medicine (Hempel, Tan), University of Toronto; Toronto Centre for Liver Disease (Biondi), University Health Network; School of Nursing (Biondi), York University; Division of Infectious Disease (Tan), St. Michael’s Hospital, Toronto, Ont.; Department of Family Medicine (Baril), Centre Hospitalier de l’Université de Montréal; Clinique de médecine urbaine du Quartier Latin (Baril), Montréal, Que.
PhD NP-PHCJean-Guy Baril
Department of Medicine (Hempel, Tan), University of Toronto; Toronto Centre for Liver Disease (Biondi), University Health Network; School of Nursing (Biondi), York University; Division of Infectious Disease (Tan), St. Michael’s Hospital, Toronto, Ont.; Department of Family Medicine (Baril), Centre Hospitalier de l’Université de Montréal; Clinique de médecine urbaine du Quartier Latin (Baril), Montréal, Que.
MDDarrell H.S. Tan
Department of Medicine (Hempel, Tan), University of Toronto; Toronto Centre for Liver Disease (Biondi), University Health Network; School of Nursing (Biondi), York University; Division of Infectious Disease (Tan), St. Michael’s Hospital, Toronto, Ont.; Department of Family Medicine (Baril), Centre Hospitalier de l’Université de Montréal; Clinique de médecine urbaine du Quartier Latin (Baril), Montréal, Que.
MD PhD
Data supplements
Earn CPD Credits
This article is eligible for 0.5 Mainpro+ credits.
Did you read this article?
Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.
Related Articles
- Hempel, A., Biondi, M. J., Baril, J., & Tan, D. H. (2022). Prophylaxie préexposition au VIH : efficace et sous-utilisée. CMAJ, 194(45), E1544-E1550. Accessed September 26, 2023. https://doi.org/10.1503/cmaj.220645-f.
In this issue
Article tools
Respond to this article
Pre-exposure prophylaxis for HIV: effective and underused
Amanda Hempel, Mia J. Biondi, Jean-Guy Baril, Darrell H.S. Tan
CMAJ Sep 2022, 194 (34) E1164-E1170; DOI: 10.1503/cmaj.220645
Jump to section
- Article
- What is pre-exposure prophylaxis for HIV?
- How effective is pre-exposure prophylaxis for HIV?
- Who should be offered pre-exposure prophylaxis for HIV?
- How is pre-exposure prophylaxis prescribed and monitored?
- What proportion of eligible patients in Canada are taking pre-exposure prophylaxis?
- What barriers exist for patients in accessing pre-exposure prophylaxis?
- What strategies can be used to increase appropriate use of pre-exposure prophylaxis?
- Conclusion
- Acknowledgement
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.